This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Mar 9;74(5):942-943.

doi: 10.1093/cid/ciab619.

Reply to McFarland et al

Emily Heil¹, Anthony Harris², Surbhi Leekha²

Affiliations

Affiliations

¹ University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
² University of Maryland School of Medicine, Baltimore, Maryland, USA.

PMID: 34240136
DOI: 10.1093/cid/ciab619

Comment

Reply to McFarland et al

Emily Heil et al. Clin Infect Dis. 2022.

. 2022 Mar 9;74(5):942-943.

doi: 10.1093/cid/ciab619.

Authors

Emily Heil¹, Anthony Harris², Surbhi Leekha²

Affiliations

¹ University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
² University of Maryland School of Medicine, Baltimore, Maryland, USA.

PMID: 34240136
DOI: 10.1093/cid/ciab619

No abstract available

PubMed Disclaimer

Comment on

A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL, Harris AD, Brown C, Seung H, Thom KA, von Rosenvinge E, Sorongon S, Pineles L, Goodman KE, Leekha S. Heil EL, et al. Clin Infect Dis. 2021 Oct 20;73(8):1330-1337. doi: 10.1093/cid/ciab417. Clin Infect Dis. 2021. PMID: 33972996
Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes.
McFarland LV, Kullar R, Maziade PJ, Goldstein EJC. McFarland LV, et al. Clin Infect Dis. 2022 Mar 9;74(5):941-942. doi: 10.1093/cid/ciab618. Clin Infect Dis. 2022. PMID: 34245249 Free PMC article. No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.